CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Operating Income Growth by Quarter and Year

Atara Biotherapeutics,'s Operating Income results by quarter and year




ATRA Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -81.82 -35.80 -18.75
III Quarter September - -60.22 -31.66 -25.94
II Quarter June - -52.62 -27.91 -19.49
I Quarter March -67.89 -42.45 -26.16 -17.06
FY   -67.89 -237.11 -121.53 -81.24



ATRA Operating Income first quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the first quarter recorded Operating Loss of $ -67.89 millions.

According to the results reported in the first quarter, Atara Biotherapeutics, Inc. achieved the best Operating Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


ATRA Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s first quarter 2019 Operating Income $ -67.89 millions ATRA's Income Statement
Atara Biotherapeutics,'s first quarter 2018 Operating Income $ -42.45 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Operating Income Growth >>


ATRA Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q Operating Income Comment
Despite the fact, that Atara Biotherapeutics, Inc. in the I. Quarter 2019 showed Operating Loss of $ -67.89 millions, it should be said, that those numbers show recovery compare to the -81.82 millions in the forth quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q Operating Income Comment
Even if Atara Biotherapeutics, Inc. in the I. Quarter 2019 admitted Operating Loss of $ -67.89 millions, some analyst point out, that current results show slight up side relative to the -81.82 millions in the forth quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ATRA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ATRA's Competitors
Operating Income Growth for Atara Biotherapeutics,'s Suppliers
Operating Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2019
Staar Surgical Co  95.87 %$ 95.870 millions
Biotelemetry, Inc.  95.67 %$ 95.665 millions
Alexion Pharmaceuticals, Inc.  93.27 %$ 93.269 millions
Integrated Biopharma Inc  87.42 %$ 87.424 millions
Repligen Corp  86.93 %$ 86.931 millions
Hill-rom Holdings, Inc.  76.36 %$ 76.356 millions
Haemonetics Corporation  67.12 %$ 67.117 millions
Surmodics Inc  64.76 %$ 64.762 millions
Lifeloc Technologies, Inc  54.09 %$ 54.091 millions
Jazz Pharmaceuticals Plc  52.31 %$ 52.315 millions
Pro Dex Inc  41.93 %$ 41.930 millions
Iradimed Corp  39.23 %$ 39.227 millions
Abiomed Inc  37.47 %$ 37.467 millions
Addus Homecare Corp  36.88 %$ 36.878 millions
Techcare Corp.  36.50 %$ 36.502 millions
Tenax Therapeutics, Inc.  35.87 %$ 35.871 millions
West Pharmaceutical Services Inc  32.40 %$ 32.397 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AWSM's Profile

Stock Price

AWSM's Financials

Business Description

Fundamentals

Charts & Quotes

AWSM's News

Suppliers

AWSM's Competitors

Customers & Markets

Economic Indicators

AWSM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071